Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
I write about the brain and other strange natural phenomena.
A synthetically engineered strain of E. coli, stripped of non-essential parts, could boost the bug’s industrial power.
In the wake of scientific fraud in South Korea, researchers are renewing their race to clone stem cells.
Advanced imaging methods may reveal how this ancient healing technique affects the brain.
A gene therapy pioneer explains how new delivery mechanisms could help revive the once-promising technology.
Will two broad patents hinder embryonic stem cell research?
China could provide a new network to safely test therapies for paralyzed patients.
Synthetically engineered microorganisms could provide a much cheaper way to manufacture drugs.
Kari Stefansson, founder and CEO of deCode Genetics, explains why gene hunting provides tailor-made drug targets.
Genizon is using the genetic homogeneity of French Canadians to find new drug targets – and redefine human disease.
A new type of PET imaging technique could eventually help doctors diagnose and head off the disease before symptoms appear.